Literature DB >> 28525750

Lung Cancer: A Wily Genetic Opponent.

Peggy P Hsu1, Alice T Shaw2.   

Abstract

In two companion reports, the TRACERx consortium investigates tumor heterogeneity and evolution in early-stage non-small cell lung cancer. The studies highlight the prognostic value of copy-number heterogeneity assessment in tumor biopsies and circulating tumor DNA detection in plasma and suggest that tracking the evolution of lung cancers might aid clinical practice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28525750     DOI： 10.1016/j.cell.2017.05.001

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  3 in total

1.  MicroRNA-199-3p targets Sp1 transcription factor to regulate proliferation and epithelial to mesenchymal transition of human lung cancer cells.

Authors:  Jiajia Fu; Tong Li; Xiaozhen Jiang; Bin Xia; Lijuan Hu
Journal:  3 Biotech       Date:  2021-06-22       Impact factor: 2.893

2.  Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.

Authors:  Yong Li; Fengjun Cao; Mingxing Li; Pindong Li; Yuandong Yu; Longchao Xiang; Tao Xu; Jinhua Lei; Yun Yan Tai; Jianyong Zhu; Bingbing Yang; Yingpin Jiang; Xiufang Zhang; Long Duo; Ping Chen; Xiongjie Yu
Journal:  J Exp Clin Cancer Res       Date:  2018-10-29

3.  Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis.

Authors:  Ziyu Cheng; Zhihui Li; Ling Gu; Liqiu Li; Qian Gao; Xiongfei Zhang; Jin Fu; Yuanyuan Guo; Qirui Li; Xu Shen; Meijuan Chen; Xu Zhang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.